Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
- PMID: 33142704
- PMCID: PMC7694072
- DOI: 10.3390/biomedicines8110464
Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
Abstract
This review aims to be an update of Bioengineered Artificial Skin Substitutes (BASS) applications. At the first moment, they were created as an attempt to replace native skin grafts transplantation. Nowadays, these in vitro models have been increasing and widening their application areas, becoming important tools for research. This study is focus on the ability to design in vitro BASS which have been demonstrated to be appropriate to develop new products in the cosmetic and pharmacology industry. Allowing to go deeper into the skin disease research, and to analyze the effects provoked by environmental stressful agents. The importance of BASS to replace animal experimentation is also highlighted. Furthermore, the BASS validation parameters approved by the OECD (Organisation for Economic Co-operation and Development) are also analyzed. This report presents an overview of the skin models applicable to skin research along with their design methods. Finally, the potential and limitations of the currently available BASS to supply the demands for disease modeling and pharmaceutical screening are discussed.
Keywords: animal experimentation; atopic dermatitis; bioengineered artificial skin substitutes; fibroblasts; keratinocytes; product testing; psoriasis; regenerative medicine; tissue engineering; transepidermal water loss.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Chandra P.K., Soker S., Atala A. Tissue engineering: Current status and future perspectives. In: Lanza R., Langer R., Vacanti J., Atala A., editors. Principles of Tissue Engineering. Volume 7. Academic Press; Winston-Salem, NC, USA: 2020. p. 1800457.
-
- Fernández-González A., Lizana-Moreno A., Ruiz-Garcia A., Guerrero-Calvo J., Espinosa O., Fernández N., Ordonez-Luque A., Sierra-Sanchez A., Arias-Santiago S. Optimization of an autologous human skin model under GMP guidelines. Cytotherapy. 2017;19:S232–S233. doi: 10.1016/j.jcyt.2017.02.338. - DOI
-
- Carriel V., Garzón I., Jiménez J.M., Oliveira A.C.X., Arias-Santiago S., Campos A., Sánchez-Quevedo M.C., Alaminos M. Epithelial and stromal developmental patterns in a novel substitute of the human skin generated with fibrin-agarose biomaterials. Cells Tissues Organs. 2012;196:1–12. doi: 10.1159/000330682. - DOI - PubMed
